Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
Key Attributes of the Successful Med Student/Resident
Friday, May 3, 2024
9:05 AM – 9:20 AM
CT
Location: S401ab
Speaker(s)
Adam S. Arthur, MD, MPH (he/him/his)
Professor
UTHSC, Semmes-Murphey Clinic
Memphis, TN, US
Disclosure(s):
Adam S. Arthur, MD, MPH
: Arsenal Medical: Consultant (Ongoing); Azimuth: Stock Shareholder (excluding mutual funds) (Ongoing); Balt: Consultant (Ongoing), Grant/Research Support (Ongoing); Bendit: Stock Shareholder (excluding mutual funds) (Ongoing); Cerebrotech: Stock Shareholder (excluding mutual funds) (Ongoing); Cerenovus: Grant/Research Support (Ongoing); Endostream: Stock Shareholder (excluding mutual funds) (Ongoing); Johnson & Johnson: Consultant (Ongoing); Magneto: Stock Shareholder (excluding mutual funds) (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); Mentice: Stock Shareholder (excluding mutual funds) (Ongoing); Microvention: Consultant (Ongoing), Grant/Research Support (Ongoing); Neuros Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Penumbra: Consultant (Ongoing), Grant/Research Support (Ongoing); Perfuze: Consultant (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); RevBio: Stock Shareholder (excluding mutual funds) (Ongoing); Scientia: Consultant (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Serenity: Stock Shareholder (excluding mutual funds) (Ongoing); Siemens: Consultant (Ongoing), Grant/Research Support (Ongoing); Stryker: Consultant (Ongoing); Synchron: Stock Shareholder (excluding mutual funds) (Ongoing); Tulavi Therapeutics, Inc.: Stock Shareholder (excluding mutual funds) (Ongoing); Vastrax: Stock Shareholder (excluding mutual funds) (Ongoing); VizAi: Stock Shareholder (excluding mutual funds) (Ongoing)